Form4insider filings, from the source

SEC Form 4 · accession 0001225208-15-005593

WEST PHARMACEUTICAL SERVICES INC · WST

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Heino Lennartz
Officer — President Europe
Period of report
Feb 23, 2015
Accepted (ET)
Feb 25, 2015 · 10:44 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 23, 2015M9,458$21.22A39,769D
Common StockFeb 23, 2015M8,582$20.425A48,351D
Common StockFeb 23, 2015S3,000$53.5619D45,351D
Common StockF1Feb 23, 2015S8,582$53.41D36,769D
Common StockFeb 23, 2015S9,458$53.35D27,311D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)$21.22Feb 23, 2015M9,458DFeb 21, 2013Feb 21, 2022Common Stock9,4589,431D
Stock Option (Right to Buy)$20.425Feb 23, 2015M8,582DFeb 22, 2012Feb 21, 2021Common Stock8,5820D

Explanation of responses